Press

News Reports  |   Press Releases  |   Videos  |   Archived Press

 

News Reports

Newly Discovered Link Between the Appendix and Parkinson’s Disease Could Point to the Way to Treatments
FierceBiotech, October 31, 2018
Read More

Renovia Closes on $42 Million Series B with CEO Marc Beer
Chronicle of the Week: October 19, 2018
Read More

A promising new minimally invasive procedure for skin contouring
Dermatology Times: October 17, 2018
Read More

GlaxoSmithKline Helps Immunometabolism Startup Sitryx to $30M Round
Fierce Biotech: October 8, 2018
Read More

Verastem Wins FDA Approval for Blood Cancer Drug
Boston Globe: September 25, 2018
Read More

Alnylam, Founded by Westphal, Sharp, Schimmel, Receives Approval for First RNAi Therapy
Wall Street Journal: August 10, 2018
Read More

Bicycle Therapeutics Ahead of the Curve in Fight Against Cancer
Business Weekly: July 13, 2018
Read More

Biotech Firm Grail Takes the First Steps in its Quest for a Blood Test for Cancer
Forbes: June 2, 2018
Read More

Axial Co-Founder Sarkis Mazmanian: What's Living in You?
Discover how a world of microbes living in and on you can make you sick-and keep you healthy. PBS, NOVA: May 2, 2018
Watch Nova

One Scientist’s Marathon Quest for the Exercise Pill
Bloomberg Businessweek: October 17, 2017
Read More

Silicon Valley Startup Grail Sees Hope for Cancer Blood Test
Bloomberg News: August 9, 2017
Read More

Rich Aldrich Honored as One of the 100 Most Influential Visionaries in Biotech
Scientific American Worldview: The Visionaries who Continue to Reshape Biotechnology – and the World
Read More

 

Press Releases

Renovia Appoints John A. Fallon, M.D. to Its Board of Directors
Read More

ArcherDX's Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by FDA
Read More

Calithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the Company’s Pipeline
Read More

KalVista Pharmaceuticals Provides Development Update and 2019 Clinical Plans
Read More

Verastem Oncology Outlines Strategic Priorities for 2019 and Highlights Recent Progress
Read More

Recros Medica's Rotational Fractional Resection Hits the Sweet Spot for a More Defined Neckline
Read More

GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection
Read More

KalVista Pharmaceuticals Provides Clinical Update on KVD900
Read More

Renovia Launches a Multi-Center RCT to Study Next-Generation leva® Pelvic Digital Therapeutic System for UI
Read More

Sygnature Discovery & Sitryx Therapeutics Enter Drug Discovery Deal
Read More

Verastem Oncology Reports Third Quarter 2018 Financial Results
Read More

Verastem Oncology Announces Presentation of Preclinical Data Supporting Dual PI3K-delta and PI3K-gamma Inhibition in Combination with Immunotherapy
Read More

Axial Biotherapeutics Strengthens Senior Management Team with Appointment of Jeff Young as Chief Financial Officer
Read More

GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at ESMO
Read More

Recros Medica Showcases Interim Data on Rotational Fractional Resection Technology
Read More

New Biopharmaceutical Company Sitryx Launches with $30 Million Fundraising to Develop Disease Modifying Therapeutics in Immunometabolism
Read More

Merck KGaA, Darmstadt, Germany Selects ArcherDX for Strategic Global Companion Diagnostic Assay Development Collaboration
Read More

GRAIL Announces Appointment of Renée Galá as Chief Financial Officer
Read More

Bicycle Therapeutics’ Founder Sir Gregory Winter Awarded Nobel Prize in Chemistry
Read More

Recros Medica Unveils the Nuvellus™ Brand for Its Novel Rotational Fractional Resection Technology
Read More

Verastem Oncology Signs Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China
Read More

Millendo Therapeutics Appoints Acceleron CEO Habib Dable to its Board of Directors
Read More

Longwood-Founded Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules
Read More

KalVista Pharmaceuticals Reports Fiscal First Quarter Results
Read More

Millendo Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with Classic CAH
Read More

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the US
Read More

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the US
Read More

KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares
Read More

ArcherDX Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
Read More

Twentyeight-Seven Therapeutics Launches with a $65 Million Series A Funding
Read More

Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax
Read More

Colorescience Product Wins Second O-Ward
Read More

Amgen Co-Founder and NAS Member Marvin H. Caruthers, PhD, Joins Board of ArcherDX
Read More

Renovia Completes $42.3 Million Series B Financing
Read More

Colorescience Partners with HydraFacial
Read More

GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors
Read More

OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
Read More

KalVista Pharmaceuticals advancing pipeline; $14.6M raised
Read More

Colorescience Receives Patent for Formulation of Even Up® Clinical Pigment Perfector
Read More

Recros Medica Announces New Patent Issued by USPTO
Read More

Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Announce Collaboration to Target Gastrointestinal Metabolites that May Contribute to Parkinson’s Disease
Read More

GRAIL Announces Data on Detection of Early-Stage Lung Cancers
Read More

Bicycle Therapeutics Announces Formation of Scientific Advisory Board
Read More

Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with Thrombogenics
Read More

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
Read More

GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing
Read More

Axial Reports Findings of Elevated 4-EPS in Children with Autism Spectrum Disorder
Read More

Colorescience Launching in the UK
Read More

GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection
Read More

Washington University, ArcherDX partner for MRD in pediatric AML sequencing study
Read More

FDA Accepts New Drug Application for Verastem's Duvelisib and Grants Priority Review
Read More

Flex Pharma Reports Positive RCT Phase 2 MS Study
Read More

ArcherDX and Ambry Genetics to provide immune repertoire and CAR-T- related sequencing services
Read More

ArcherDX Closes $35 Million Series A Financing
Read More

Bicycle Therapeutics and Cancer Research UK Announce Initiation of First Clinical Study of a Bicyclic Peptide (Bicycle®)
Read More

Colorescience Introduces Total Eye 3-in-1 Renewal Therapy SPF 35
Read More

Astellas Completes Acquisition of Mitobridge, Inc.
Read More

Recros Medica Closes $9M Financing, Strengthens Board
Read More

Millendo Acquires Alizé Pharma SAS to Expand Orphan Endocrinology Pipeline
Read More

Millendo Therapeutics Announces Positive Phase 2 Results in Classic Congenital Adrenal Hyperplasia, Receives FDA Orphan Drug Designation
Read More

Flex Pharma Announces Positive Phase 2 ALS Results
Read More

KalVista Pharmaceuticals Announces Collaboration with Merck
Read More

Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO™ Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Read More

Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia and Sickle Cell Disease
Read More

Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
Read More

GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early
Read More

 

Videos